(Q43576740)

24 November 2017

title

Clearance kinetics of a hylan-based viscosupplement after intra-articular and intravenous administration in animal models (English)

1 reference

24 November 2017

Nancy E Larsen

1

1 reference

24 November 2017

Holly D Dursema

series ordinal

2

1 reference

24 November 2017

Cynthia T Pollak

series ordinal

3

1 reference

24 November 2017

Eugene M Skrabut

series ordinal

4

1 reference

24 November 2017

publication date

21 November 2011

1 reference

Journal of Biomedical Materials Research Part B

24 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 November 2017

volume

100

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

457-462

1 reference

Fluid movement across synovium in healthy joints: role of synovial fluid macromolecules

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.31971

Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.31971

Distribution of biologically labelled radioactive hyaluronic acid injected into joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.31971

Uptake and degradation of hyaluronan in lymphatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.31971

Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.31971

Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.31971

Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.31971

Hylan G-F 20 single-injection formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.31971

A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.31971

21 January 2018

Identifiers

DOI

10.1002/JBM.B.31971

1 reference

24 November 2017

1 reference